Ovarian steroids regulate neuropeptides in the trigeminal ganglion

被引:93
作者
Puri, V
Cui, L
Liverman, CS
Roby, KF
Klein, RM
Welch, KMA
Berman, NEJ
机构
[1] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA
[2] Univ Med & Sci, Dept Neurol, N Chicago, IL 60064 USA
[3] Univ Med & Sci, Off President Rosalind Franklin, N Chicago, IL 60064 USA
关键词
galanin; neuropeptide Y; trigeminal; estrous cycle; migraine; estrogen receptor;
D O I
10.1016/j.npep.2005.04.002
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Women are more than three times as likely as men to experience migraine headaches and temporomandibular joint pain, and painful episodes are often linked to the menstrual cycle. To understand how hormone levels may influence head and face pain, we assessed expression of pain-associated neuropeptides and estrogen receptor alpha (ER alpha) during the natural estrous cycle in mice. Gene expression was analyzed in the trigeminal ganglia of cycling female mice at proestrus, estrus and diestrus using RT-PCR. Peptide/protein expression in trigeminal neurons was analyzed using immunohistochemistry. ER alpha mRNA was present at all stages and highest at estrus. ER alpha protein was present in the cytoplasm of medium-sized and small trigeminal neurons. ER alpha immunoreactive neurons were most common at diestrus. CGRP and ANP mRNAs did not change across the estrous cycle, while expression of galanin and NPY mRNAs were strongly linked to the estrous cycle. Galanin mRNA levels peaked at proestrus, when expression was 8.7-fold higher than the diestrus levels. Galanin immunoreactivity also peaked at proestrus. At proestrus, 7.5% of trigeminal neurons contained galanin, while at estrus, 6.2% of trigeminal neurons contained galanin, and at diestrus, 4.9% of trigeminal neurons contained galanin. NPY mRNA peaked at estrus, when levels were 4.7-fold higher than at diestrus. Our findings suggest that estrogen receptors in trigeminal neurons modulate nociceptive responses through effects on galanin and NPY. Variations in neuropeptide content in trigeminal neurons across the natural estrous cycle may contribute to increases in painful episodes at particular phases of the menstrual cycle. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 55 条
[1]
Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons [J].
Abdulla, FA ;
Smith, PA .
NEUROSCIENCE, 1999, 89 (01) :43-60
[2]
Behavioral characterization of neuropeptide Y knockout mice [J].
Bannon, AW ;
Seda, J ;
Carmouche, M ;
Francis, JM ;
Norman, MH ;
Karbon, B ;
McCaleb, ML .
BRAIN RESEARCH, 2000, 868 (01) :79-87
[3]
FACIAL RECEPTIVE-FIELDS OF TRIGEMINAL NEURONS - INCREASED SIZE FOLLOWING ESTROGEN-TREATMENT IN FEMALE RATS [J].
BEREITER, DA ;
BARKER, DJ .
NEUROENDOCRINOLOGY, 1975, 18 (01) :115-124
[4]
Galanin receptor subtypes [J].
Branchek, TA ;
Smith, KE ;
Gerald, C ;
Walker, MW .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :109-116
[5]
ANALYSIS OF GENDER EFFECTS ON PAIN PERCEPTION AND SYMPTOM PRESENTATION IN TEMPOROMANDIBULAR PAIN [J].
BUSH, FM ;
HARKINS, SW ;
HARRINGTON, WG ;
PRICE, DD .
PAIN, 1993, 53 (01) :73-80
[6]
Carleson Joakim, 1997, Journal of Orofacial Pain, V11, P195
[7]
Estrogen and μ-opioid receptor antagonists counteract the 17β-estradiol-induced licking increase and interferon-γ reduction occurring during the formalin test in male rats [J].
Ceccarelli, I ;
Fiorenzani, P ;
Grasso, G ;
Lariviere, WR ;
Massafra, C ;
Massai, L ;
Muscettola, M ;
Aloisi, AM .
PAIN, 2004, 111 (1-2) :181-190
[8]
Local action of estrogen and thyroid hormone on vasoactive intestinal peptide (VIP) and galanin gene expression in the rat anterior pituitary [J].
Degerman, A ;
Chun, D ;
Nguyen, TB ;
Bravo, DT ;
Alanis, J ;
Rökaeus, Å ;
Waschek, JA .
NEUROPEPTIDES, 2002, 36 (01) :50-57
[9]
MICROINJECTION OF NEUROPEPTIDE-Y INTO THE SUPERFICIAL DORSAL HORN REDUCES STIMULUS-EVOKED RELEASE OF IMMUNOREACTIVE SUBSTANCE-P IN THE ANESTHETIZED CAT [J].
DUGGAN, AW ;
HOPE, PJ ;
LANG, CW .
NEUROSCIENCE, 1991, 44 (03) :733-740
[10]
New therapeutic target in primary headaches - blocking the CGRP receptor [J].
Edvinsson, L .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) :377-383